A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. - Saad,F.; Gleason,D.M.; Murray,R.; Tchekmedyian,S.; Venner,P.; Lacombe,L.; Chin,J.L.; Vinholes,J.J.; Goas,J.A.; Chen,B. (J Natl Cancer Inst, 2002)